According to the American Herbal Products Association (AHPA), FDA will publish a draft guidance describing the minimum data elements for serious adverse event reports for dietary supplements on Monday, October 15th. A pre-publication copy of the draft guidance can be accessed at http://www.cfsan.fda.gov/~dms/dsaergui.html.
 
The publication of this guidance fulfills a portion of FDA’s requirement under the Dietary Supplement and Nonprescription Drug Consumer Protection Act, which goes into effect on December 22, 2007. The agency stated that this document will also provide guidance on how, when, and where to submit a serious adverse event report for a dietary supplement, as well as on records maintenance and access for serious and non-serious adverse event reports and related documents. The agency also disclosed that it is preparing a separate guidance on the reporting of serious adverse events associated with nonprescription human drug products that were also affected by the legislation passed by the U.S. Congress last year. As is standard for the issuance of such guidance, there will be a 60-day period during which comments may be submitted.
 
The American Herbal Products Association (AHPA) had previously scheduled an educational tele-seminar for Tuesday, October 16 (1:00-3:00 pm Eastern), titled Adverse Event Reporting: Strategies for Compliance. This educational event will now incorporate the newly released FDA guidance. For further information, see http://www.ahpa.org/Default.aspx?tabid=69&aId=425&zId=1